Evidence map›Paper›PMID 41114105›Full record

ArticleWorld journal of gastrointestinal oncology2025

Tao Chen, An-Qiang Feng, Xiao-Ran Shen, Ni-Yi Dang, Feng Ye, Guo-Xin Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Role of microRNA-136 inWorld journal of gastrointestinal oncology · 2026
    Article
  2. World journal of gastrointestinal oncology · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tao ChenThe First Clinical Medical College of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.
An-Qiang FengDepartment of Gastroenterology, Xuzhou Central Hospital, Xuzhou 221009, Jiangsu Province, China.
Xiao-Ran ShenDepartment of Gastroenterology, Nantong First People's Hospital, Nantong 226001, Jiangsu Province, China.
Ni-Yi DangDepartment of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.
Feng YeDepartment of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.
Guo-Xin ZhangDepartment of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China. nanjingmedical@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMicroRNAs play an important role in gastric cancer (GC) development following

aimTo investigate the role of miR-136 in

methodsGC and gastric epithelial cells were infected with

resultsmiR-136 expression was significantly upregulated while PDCD11 expression was significantly downregulated in early GC tissues and GC cells infected with

conclusionmiR-136 is a novel diagnostic biomarker and therapeutic target in

Indexed as

Gastric cancerHelicobacter pylorimiR-136Nuclear factor kappa-BPDCD11

Identifiers

PMID41114105
PMCPMC12531794

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.